


Healthcare News Roundup: Venture Capital
HSMN NewsFeed - 14 May 2024
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
